ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 79 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $66,000 | -13.2% | 13,460 | -6.3% | 0.00% | 0.0% |
| Q2 2021 | $76,000 | +72.7% | 14,360 | +133.6% | 0.00% | 0.0% |
| Q1 2019 | $44,000 | +57.1% | 6,148 | +372.9% | 0.00% | -50.0% |
| Q3 2017 | $28,000 | -52.5% | 1,300 | -61.8% | 0.00% | -50.0% |
| Q2 2017 | $59,000 | +2850.0% | 3,400 | +2228.8% | 0.00% | – |
| Q3 2016 | $2,000 | -89.5% | 146 | -88.1% | 0.00% | -100.0% |
| Q2 2016 | $19,000 | -95.6% | 1,227 | -92.5% | 0.00% | -95.2% |
| Q2 2015 | $429,000 | +42.1% | 16,365 | -6.0% | 0.02% | +31.2% |
| Q4 2014 | $302,000 | – | 17,415 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,601,351 | $43,963,000 | 9.03% |
| Granite Point Capital Management, L.P. | 256,031 | $4,327,000 | 3.45% |
| Opaleye Management Inc. | 285,000 | $4,817,000 | 2.84% |
| Brenner West Capital Advisors | 1,221,463 | $20,643,000 | 2.28% |
| ARMISTICE CAPITAL, LLC | 536,000 | $9,058,000 | 2.14% |
| NEXTHERA CAPITAL LP | 151,670 | $2,563,000 | 1.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 185,234 | $3,130,000 | 1.41% |
| Cheyne Capital Management (UK) LLP | 144,765 | $2,448,000 | 1.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 270,000 | $4,563,000 | 1.16% |
| Mosaic Family Wealth, LLC | 123,314 | $2,084,000 | 0.96% |